PedAM
Pediatric Disease Annotations & Medicines
| Disease | cataract |
| Symptom | C0030193|pain |
| Sentences | 11 |
| PubMedID- 23608571 | The reviewed literature indicates that cataract surgery is associated with significant postoperative pain in some patients, who should be provided with appropriate counseling and pain treatment. |
| PubMedID- 21151329 | Among the multiple factors implicated in neovascular amd, inflammation is known to play an important role in cnvm formation.6 a preliminary study of combination treatment with anti-vegf therapy and a nonsteroidal anti-inflammatory drug (nsaid), topical bromfenac (0.09%) (xibrom®; ista pharmaceuticals inc., irvine, ca), reported a synergistic effect with both improved visual outcomes as well as a decreased need for intravitreal injections.7 nepafenac 0.1% (nevanac®; alcon labs, fort worth, tx) is another topical nsaid used in the treatment of pain and inflammation associated with cataract surgery, as it has excellent corneal and scleral penetration.8 nepafenac inhibits both cox-1 and cox-2, reducing levels of prostaglandins and thromboxanes implicated in angiogenesis. |
| PubMedID- 24860628 | A 41-year-old caucasian man presented to the emergency department with left eye pain and loss of vision after complicated cataract surgery 2 days prior. |
| PubMedID- 25667741 | The patient was referred that 3 days following cataract surgery, with pain and decreased va in os and at that time, he received intravitreal injection of ceftazidime (2.25 mg), vancomycin hydrochloride (1.0 mg) and dexamethasone sodium (0.4 mg) after a vitreous tap was taken. |
| PubMedID- 21751945 | Conclusions: bromfenac ophthalmic solution 0.09% dosed once daily is clinically safe and effective for the treatment of ocular inflammation and the reduction of ocular pain associated with cataract surgery. |
| PubMedID- 25725037 | These indications are (1) pain and inflammation associated with cataract surgery, (2) pain associated with corneal refractive surgery, (3) inhibition of intraoperative miosis, and (4) seasonal allergic conjunctivitis. |
| PubMedID- 23225093 | The pain experience and cooperation of patients in consecutive cataract surgery. |
| PubMedID- 21762992 | Conclusions: bromfenac 0.09% dosed once daily was clinically safe and effective for reducing and treating ocular inflammation and pain associated with cataract surgery. |
| PubMedID- 21932014 | Phase ii placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in japanese patients. |
| PubMedID- 25050180 | pain intensity varies with cataract type and stage of surgery. |
| PubMedID- 21383946 | The inflammation and pain associated with cataract surgery is a good model for evaluating treatment of intraocular inflammation. |
Page: 1